Comparison of patient characteristics in nodal and nonnodal groups
. | Nodal group . | Nonnodal group . | P . |
|---|---|---|---|
| Patients | |||
| No. | 43 | 37 | |
| M/F | 2.3/1 | 2/1 | 1.0 |
| Mean age, y (range) | 65 (42-87) | 63 (36-81) | .58 |
| Clinical (%) | |||
| Splenomegaly | 25/43 (58) | 28/37 (76) | .15 |
| GI tract | 8/43 (19) | 2/37 (5) | .1 |
| CD38, 30% or more positive (%) | 32/34 (94) | 16/33 (48) | < .001 |
| IgVH genes (%) | |||
| 98% or higher homology | 28/31 (90) | 15/34 (44) | |
| 97% homology | 3/31 (10) | 3/34 (9) | < .001 |
| Less than 97% homology | 0/31 | 16/34 (47) | |
| Karyotype (%) | |||
| Complex | 11/11 (100) | 9/17 (53) | .01 |
| Single | 0/11 | 8/17 (47) | |
| Median survival, mo (95% confidence limits) | 30 (10-50) | 79 (22-136) | .005 |
. | Nodal group . | Nonnodal group . | P . |
|---|---|---|---|
| Patients | |||
| No. | 43 | 37 | |
| M/F | 2.3/1 | 2/1 | 1.0 |
| Mean age, y (range) | 65 (42-87) | 63 (36-81) | .58 |
| Clinical (%) | |||
| Splenomegaly | 25/43 (58) | 28/37 (76) | .15 |
| GI tract | 8/43 (19) | 2/37 (5) | .1 |
| CD38, 30% or more positive (%) | 32/34 (94) | 16/33 (48) | < .001 |
| IgVH genes (%) | |||
| 98% or higher homology | 28/31 (90) | 15/34 (44) | |
| 97% homology | 3/31 (10) | 3/34 (9) | < .001 |
| Less than 97% homology | 0/31 | 16/34 (47) | |
| Karyotype (%) | |||
| Complex | 11/11 (100) | 9/17 (53) | .01 |
| Single | 0/11 | 8/17 (47) | |
| Median survival, mo (95% confidence limits) | 30 (10-50) | 79 (22-136) | .005 |